Fallopian Tube Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Cancer survivor gave birth to quadruplets after IVF | Daily Mail Online - Daily Mail



Daily Mail
 
Cancer survivor gave birth to quadruplets after IVF | Daily Mail Online 
Daily Mail
Mother-of-five Virginia Johnson, from Arizona, gave birth to a daughter and welcomed quadruplets just years after believing bladder cancer had ended her dreams of having a family.
Mum whose life was saved by miscarriage which detected bladder ... Mirror.co.uk

all 2 news articles » 


Medical Nightmare: Woman Contracted Pancreatic Cancer From Transplanted Organ, Lawsuit Claims - Newsweek



Newsweek
 
Medical Nightmare: Woman Contracted Pancreatic Cancer From Transplanted Organ, Lawsuit Claims 
Newsweek
A California woman claimed that her life-saving organ transplant gave her cancer. ANNE-CHRISTINE POUJOULAT/AFP/Getty Images. According to the document. West received a kidney and pancreas transplant on June 4, 2016. On December 17 of the same year, the ...

 


Fallopian Tube Mutation Could Lead to Early Diagnosis of Ovarian Cancer - Specialty Pharmacy Times



Fallopian Tube Mutation Could Lead to Early Diagnosis of Ovarian Cancer 
Specialty Pharmacy Times
Screening for cancer cells in the fallopian tubes of high-risk patients may result in early diagnosis of ovarian cancer before it progresses, according to a new study published by Nature Communications. Previous studies in mice and humans have shown ...

 


Maintenance Rucaparib Granted Priority Review for Ovarian Cancer - Targeted Oncology



Targeted Oncology
 
Maintenance Rucaparib Granted Priority Review for Ovarian Cancer 
Targeted Oncology
All enrolled patients had received ?2 prior platinum-based therapies, and continued to have platinum-sensitive ovarian cancer (defined as progression in ?6 months on their last platinum-based therapy). Oral rucaparib was administered at 600 mg twice ...

and more » 


Smoothened Homolog - Pipeline Review, H2 2017; New Report Launched - Digital Journal



Smoothened Homolog - Pipeline Review, H2 2017; New Report Launched 
Digital Journal
... Myeloblastic Leukemia), Adenocarcinoma Of The Gastroesophageal Junction, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gorlin Syndrome (Basal Cell Nevus Syndrome), Medulloblastoma, Cirrhosis, Esophageal Cancer, Idiopathic Pulmonary Fibrosis ...

and more » 


A New Study Links Birth Control Pills and Breast Cancer?Here's What You Need to Know - Vogue.com



Vogue.com
 
A New Study Links Birth Control Pills and Breast Cancer?Here's What You Need to Know 
Vogue.com
?You don't get additional ovarian cancer benefits after five years of the pill, so talk with your doctor about nonhormonal options or even, for women who are finished having children, consider permanent contraception like tubal ligation,? she says of ...

and more » 


Woman Who Beat Cancer Gives Birth to Quadruplets After She Was Told She'd Never Get Pregnant - WSLS 10



WSLS 10
 
Woman Who Beat Cancer Gives Birth to Quadruplets After She Was Told She'd Never Get Pregnant 
WSLS 10
She explained that when she was just 13 years old, she had to have her right fallopian tube and ovary removed. In her early 20s, doctors diagnosed her with Polycystic ovary syndrome (PCOS). When she got pregnant at 31 years old, she was told her ...
Cancer survivor gives birth to quadruplets and a daughter after IVF 9Honey

all 4 news articles » 


FDA Grants Priority Review to Maintenance Rucaparib for Ovarian Cancer - OncLive



OncLive
 
FDA Grants Priority Review to Maintenance Rucaparib for Ovarian Cancer 
OncLive
The FDA has granted a priority review to a supplemental new drug application (sNDA) for rucaparib (Rubraca) for use as a maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a ...
Clovis PARP drug gets fast US review in new ovarian cancer use pharmaphorum

all 74 news articles » 


New research may lead to earlier detection of ovarian cancer - Las Vegas Review-Journal



Las Vegas Review-Journal
 
New research may lead to earlier detection of ovarian cancer 
Las Vegas Review-Journal
Dr. Kristian Hedstrom of the Massachusetts-based Adelson Foundation, which helped fund the study co-authored by scientists from Johns Hopkins University and the University of Pennsylvania, said the research suggests the genomic roots of many ovarian ...

 


Fate Therapeutics Announces First Subject Treated with FATE-NK100 in APOLLO Study for Recurrent Ovarian Cancer - GlobeNewswire (press release)



Fate Therapeutics Announces First Subject Treated with FATE-NK100 in APOLLO Study for Recurrent Ovarian Cancer 
GlobeNewswire (press release)
The APOLLO study is an open-label, accelerated dose-escalation, Phase 1 clinical trial of FATE-NK100 in subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer. Up to three dose levels of FATE-NK100 are intended to be assessed to ...